How to treat prolactin-secreting pituitary tumors

The treatment of prolactinoma mainly includes drug therapy, surgical treatment and radiotherapy, among which drug therapy is often the first choice. For prolactinoma, drug therapy usually uses dopamine receptor agonists, such as bromocriptine and cabergoline. These drugs can effectively reduce prolactin levels and shrink the tumor. Surgical treatment is suitable for cases where drugs are ineffective or cannot be tolerated. The commonly used method is to remove the tumor through the transsphenoidal approach. Radiotherapy is used for residual or recurrent tumors after surgery.

Prolactinoma refers to a tumor caused by excessive secretion of prolactin from the pituitary gland. It can not only cause symptoms such as galactorrhea and irregular menstruation, but may also cause more serious health problems such as infertility. In drug treatment, bromocriptine and cabergoline are currently the two most commonly used dopamine receptor agonists. Bromocriptine is a long-acting drug that usually takes effect quickly and can effectively control symptoms and shrink tumors for most patients. Cabergoline is known for better tolerance and fewer adverse reactions. Surgical treatment mainly uses microsurgery via the transsphenoidal approach, which makes traditional craniotomy less traumatic and faster to recover. Radiotherapy is suitable for cases with residual parts or regrowth that do not respond to drugs after surgery, such as gamma knife or proton therapy, to control tumor growth for a longer period of time. In addition to treatment, routine follow-up and monitoring of prolactin levels are essential to adjust the treatment plan in a timely manner.

Prolactinoma refers to a tumor caused by excessive secretion of prolactin from the pituitary gland. It can not only cause symptoms such as galactorrhea and irregular menstruation, but may also cause more serious health problems such as infertility. In drug treatment, bromocriptine and cabergoline are currently the two most commonly used dopamine receptor agonists. Bromocriptine is a long-acting drug that usually takes effect quickly and can effectively control symptoms and shrink tumors for most patients. Cabergoline is known for better tolerance and fewer adverse reactions. Surgical treatment mainly uses microsurgery via the transsphenoidal approach, which makes traditional craniotomy less traumatic and faster to recover. Radiotherapy is suitable for cases with residual parts or regrowth that do not respond to drugs after surgery, such as gamma knife or proton therapy, to control tumor growth for a longer period of time. In addition to treatment, routine follow-up and monitoring of prolactin levels are essential to adjust the treatment plan in a timely manner.

When deciding on a treatment plan, a personalized plan should be developed based on each patient's specific condition and symptoms. Patients usually need to work closely with endocrinologists and neurosurgeons to ensure the effectiveness and safety of treatment. Maintaining a good lifestyle can also help improve the condition. Patients should pay attention to a balanced diet and a regular schedule to reduce stress factors. At the same time, any changes in treatment plans or adjustments in drug dosages should be made under the guidance of a doctor to avoid potential health risks. If you feel abnormal symptoms or discomfort, you should seek medical advice in a timely manner.